...
首页> 外文期刊>Clinical immunology: The official journal of the Clinical Immunology Society >Hemophagocytic lymphohistiocytosis and primary immune deficiency disorders
【24h】

Hemophagocytic lymphohistiocytosis and primary immune deficiency disorders

机译:吞噬性淋巴细胞组织细胞增生症和原发性免疫缺陷疾病

获取原文
获取原文并翻译 | 示例
           

摘要

Hemophagocytic lymphohistiocytosis (HLH) is characterized by uncontrolled immune activation and is traditionally associated with inherited gene defects or acquired causes. In addition to abnormalities in cytotoxic granules and lysosomes, various primary immune deficiency disorders (PID) have been identified among patients suffering from HLH. Our purpose was twofold: to better characterize and detail the association between PID and HLH. We found that HLH occurs infrequently among patients with PID, particularly those suffering from abnormalities that impair T cell function. The prognosis of patients suffering from PID and HLH is poor, emphasizing the need for rapid clinical and genetic diagnosis of the PID as well as initiation of appropriate management of the HLH, including allogeneic hematopoietic stem cell transplantations.
机译:吞噬性淋巴细胞组织细胞增生症(HLH)的特征在于不受控制的免疫激活,并且传统上与遗传的基因缺陷或获得性原因相关。除了细胞毒性颗粒和溶酶体的异常外,在患有HLH的患者中还发现了各种原发性免疫缺陷疾病(PID)。我们的目的是双重的:更好地表征和详述PID与HLH之间的关联。我们发现HLH在PID患者中很少发生,特别是那些患有损害T细胞功能异常的患者。患有PID和HLH的患者的预后较差,强调需要对PID进行快速的临床和遗传诊断,以及开始对HLH进行适当管理,包括同种异体造血干细胞移植。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号